prikaz prve stranice dokumenta Performance of the COMPASS-31 questionnaire with regard to autonomic nervous system testing results and medication use: a prospective study in a real-life setting
  Download
PDF 1.37 MB
Scientific paper - Original scientific paper
Performance of the COMPASS-31 questionnaire with regard to autonomic nervous system testing results and medication use: a prospective study in a real-life setting
Neurological Sciences, 39 (2018), 12; 2079-2084. https://doi.org/10.1007/s10072-018-3542-8
Ruška, Berislav; Pavičić, Tin; Pavlović, Ivan; Junaković, Anamari; Adamec, Ivan; Crnošija, Luka; Krbot Skorić, Magdalena; Habek, Mario

Institutional repository: Dr Med - University of Zagreb School of Medicine Digital Repository

Cite this document

Ruška, B., Pavičić, T., Pavlović, I., Junaković, A., Adamec, I., Crnošija, L. ... Habek, M. (2018). Performance of the COMPASS-31 questionnaire with regard to autonomic nervous system testing results and medication use: a prospective study in a real-life setting. Neurological Sciences, 39. (12), 2079-2084. doi: 10.1007/s10072-018-3542-8

Ruška, Berislav, et al. "Performance of the COMPASS-31 questionnaire with regard to autonomic nervous system testing results and medication use: a prospective study in a real-life setting." Neurological Sciences, vol. 39, no. 12, 2018, pp. 2079-2084. https://doi.org/10.1007/s10072-018-3542-8

Ruška, Berislav, Tin Pavičić, Ivan Pavlović, Anamari Junaković, Ivan Adamec, Luka Crnošija, Magdalena Krbot Skorić and Mario Habek. "Performance of the COMPASS-31 questionnaire with regard to autonomic nervous system testing results and medication use: a prospective study in a real-life setting." Neurological Sciences 39, no. 12 (2018): 2079-2084. https://doi.org/10.1007/s10072-018-3542-8

Ruška, B., et al. (2018) 'Performance of the COMPASS-31 questionnaire with regard to autonomic nervous system testing results and medication use: a prospective study in a real-life setting', Neurological Sciences, 39(12), pp. 2079-2084. doi: 10.1007/s10072-018-3542-8

Ruška B, Pavičić T, Pavlović I, Junaković A, Adamec I, Crnošija L, and sur.. Performance of the COMPASS-31 questionnaire with regard to autonomic nervous system testing results and medication use: a prospective study in a real-life setting. Neurological Sciences [Internet]. 2018 December [cited 2024 April 28];39(12):2079-2084. doi: 10.1007/s10072-018-3542-8

B. Ruška, et al., "Performance of the COMPASS-31 questionnaire with regard to autonomic nervous system testing results and medication use: a prospective study in a real-life setting", Neurological Sciences, vol. 39, no. 12, pp. 2079-2084, December 2018. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:006068. [Accessed: 28 April 2024]

Metadata
Title (english)Performance of the COMPASS-31 questionnaire with regard to autonomic nervous system testing results and medication use: a prospective study in a real-life setting
AuthorBerislav Ruška
AuthorTin Pavičić
AuthorIvan Pavlović
AuthorAnamari Junaković
AuthorIvan Adamec
AuthorLuka Crnošija
AuthorMagdalena Krbot Skorić
AuthorMario Habek
Author's institutionUniversity of Zagreb
School of Medicine
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Abstract (english)
The aim of this study was to investigate the performance of the Composite Autonomic System Score-31 (COMPASS-31) questionnaire in a real-life setting in consecutive patients referred to the laboratory for objective testing of the autonomic nervous system (ANS), with the hypothesis that COMPASS-31 results differ depending on medications and findings of the tilt table test results. One hundred seventy-one consecutive patients (125 females, mean age 41.5 ± 19.3) referred for testing of the ANS were enrolled. Before testing, all patients completed the recently validated Croatian version of COMPASS-31. The following data were systematically collected for all patients: age, sex, diagnoses, and medications. Results of COMPASS-31 were significantly higher in patients taking medications with a known influence on the ANS (p < 0.001). Patients with postural orthostatic tachycardia had significantly higher orthostatic intolerance and vasomotor domains of COMPASS-31 (p = 0.048 and p = 0.022, respectively). Patients with a cardiovagal score ≥ 1 had a significantly higher vasomotor domain of COMPASS-31 compared to patients with normal results of ANS tests (p = 0.030). These findings suggest the COMPASS-31 might be a valuable screening tool for autonomic dysfunctions, as it is associated with impaired ANS tests, but usage of medications that modify the ANS should always be taken into account.
Keywords (english)
Languageenglish
Publication typeScientific paper - Original scientific paper
Publication statusPublished
Peer reviewPeer review
Publication versionAccepted version
Journal titleNeurological Sciences
Numberingvol. 39, no. 12, pp. 2079-2084
p-ISSN1590-1874
DOIhttps://doi.org/10.1007/s10072-018-3542-8
URN:NBNurn:nbn:hr:105:006068
Publication2018-12
Document URLhttp://doi.org/10.1007/s10072-018-3542-8
Type of resourceText
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2024-03-28 10:30:45